| Code | 1801A | ||||||||||
| MA number | 24/0318/12-S | ||||||||||
| Product Form: | tbl 20x5 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 24 - ANTIHISTAMINICA, HISTAMIN | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.06.2012 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_DASLODIL 5 mg_05/2025.pdf
|
| PIL: |
PIL_DASLODIL 5 mg_otc_05/2025.pdf
|
| PIL: |
PIL_DASLODIL 5 mg_rx_05/2025.pdf
|
| Safety feature | Yes |
| Data update: | 18.10.2023 |
